Form 4: Upstream Bio Director Acquires Stock Options
SEC Form 4 Filing
Ronald C Renaud JR, a director at Upstream Bio, Inc., acquired stock options for 17,096 shares of common stock on October 10, 2024.
Summary
- On October 10, 2024, Ronald C Renaud JR, a director of Upstream Bio, Inc., acquired stock options for 17,096 shares.
- The exercise price of the stock options is $0.00.
- The options vest on the earlier of October 10, 2025, or the date of the next Annual Meeting of Stockholders, contingent upon continued service.
- The options expire on October 9, 2034.
Sentiment
Score: 5
Explanation: This is a routine filing reflecting a standard stock option grant, so the sentiment is neutral.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, such as directors, regarding the company's securities.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 10/10/2024 | Date of the stock option transaction. |
| 10/10/2025 | Earliest vesting date for the stock options. |
| 10/09/2034 | Expiration date for the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.